from 24 to 30 October
Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting
Ernest Nadal
Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge
Microsoft Teams Meeting
21-22 October 2020
This event is being held online
Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich
Unitat EM HUB
22-23 Octubre 2020
Sala d’actes Bellvitge University hospital 9.00h
Speaker Eva Gonzalez-Suarez
Transformation and Metastasis Group, Oncobell Program
12-13 November 2020
this event is being held online
Rafael Máñez
Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital
Microsoft Teams Meeting
By Joan Gómez Junyent
Directors: Javier Ariza Cardenal i Oscar Murillo Rubio
Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher
Online i en directe:
https://sinergia.l-h.cat/
Antonio Gentilella
Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona
Microsoft Teams Meeting
Juan Jose Rojas
Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona
Microsoft Teams Meeting
Rare cardiovascular diseases, such as congenital heart disease, are difficult to study given that very few patients…
Thesis: Characterization of the 40S-LARP1 complex in a model of ribosome biogenesis-addicted tumors By Carolina Martinez Herraez…
Ponència a càrrec de Carla Roca Grau, investigadora del grup de recerca en Càncer hereditari de l’IDIBELL. 21…
Bridging borders in innovation Vine a la nova edició de l’#AMP2024, el lloc on saber més sobre…
#IDIBELLextraordinaryseminar I will present – 1. aspects of cancer health disparities related to aggressive and rare breast…
Conferència: Atypical Eating Disorders (OSFED): Clinical Features, Diagnostic entity and Treatment Dra. Isabel Krug Associate Professor of…
PESSICS DE CIÈNCIA. SETMANA MUNDIAL DEL CERVELL 2024 Conferència a càrrec de Mónica Povedano. Metge del servei…
We recently identified a therapeutically exploitable NOTCH1-SIRT1-KAT7 axis in T-ALL, suggesting that directly targeting KAT7 might be…
15 de Març, Sala Pau Viladiu, a les 11.00 Tesi: Deciphering pathomechanisms underlying genetic lipid disorders of…
Àrea d’influència de l’Hospital de Viladecans Coordinació: Dra. Ana Ponce, Adjunta del Servei de Medicina Interna de…
